Stock screenerAll disclosures →
EDGAR →
AGIO
Conviction 66HealthcareScan · Mon, Aug 10, 2026Bullish engulfing
AGIO$32.61+1.04%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 1.34M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price32.61
Change+1.04%
Gap-1.41%
Rel volume1.83×
Avg volume1.28M
Avg $ vol44.17M
SMA 2035.28
SMA 5034.55
SMA 20031.32
Price vs 50-5.63%
Price vs 200+4.10%
MA stackmixed
50/200 cross—
Supertrenddown · 37.04
RSI (14)42
MACD hist-0.52
MACD cross—
Stoch %K / %D36 / 30
ADX (14)28
+DI / −DI19 / 29
RSI divergence—
MACD divergence—
ATR %+5.72%
ADR %5.18%
52w high45.49
52w low22.34
From 52w high-28.32%
Above 52w low+45.95%
New 52w highNo
SqueezeOff
Bollinger width37.31%
%B0.30
Donchian pos30.33%
Donchian high40.54
Donchian low29.15
AVWAP (52w high)29.42
vs AVWAP high+10.82%
AVWAP (52w low)29.38
vs AVWAP low+10.96%
OBV trendFlat
Chaikin MF (20)0.04
Today vs 20d1.83×
Avg vol (14d)1.34M
Avg vol (20d)1.28M
Avg $ vol (20d)44.17M
Market cap1.95B
RS 3m (vs SPY)+11.52%
RS 6m (vs SPY)+7.34%
RS line new highNo
Trend template3/8
Technical rank48.2
1 week+6.76%
1 month-20.92%
3 months+17.33%
6 months+22.90%
1 year-12.02%
YTD+19.96%
P/E-4.72
P/B1.90
P/S36.03
P/FCF-5.16
EPS-7.12
Div yield—
ROE-40.23%
ROA-37.24%
Debt/Eq—
Current10.22
EV/EBITDA-3.98
Gross margin—
Net margin-764.01%
Rev growth48.03%
EPS growth-161.27%
Price target41.00
Target upside25.75%
Analyst ratingBuy
Institutional116.41%
Ent. value1.85B
Revenue44.74M
Net income-100.7M
Gross profit—
Free cash flow-377.29M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees540
ListedWed, Jul 24, 2013
Free float57.6M
Float %98.3%
Short interest6.63M
Days to cover6.4d
Short volume60.9%
Squeeze score74 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.69 vs −$1.86
Last surprise+9.1% beat
Setup gradeB
Conviction66 / 100
Pattern quality—
Tech rank48.2 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish engulfing
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in AGIO · 3 recent
Insider activity
SEC Form 4 transactions in AGIO · 3 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Gheuens Sarah Chief Medical Officer · Common stock · 2026-08-04 | Sell | 30K | $914K | 2026-08-04 | 2026-08-06 |
Backstrom Jay T. Director · Common stock · 2026-07-08 | Grant | 1.45K | — | 2026-07-08 | 2026-07-10 |
Backstrom Jay T. Director · Restricted stock units · 2026-07-08 | Exercise | 1.45K | — | 2026-07-08 | 2026-07-10 |
CAPELLO JEFFREY D Director · Common stock · 2026-06-13 | Exercise | 1.98K | — | 2026-06-13 | 2026-06-16 |
CAPELLO JEFFREY D Director · Restricted stock units · 2026-06-13 | Exercise | 1.98K | — | 2026-06-13 | 2026-06-16 |
Owen Adams Catherine Director · Common stock · 2026-06-13 | Exercise | 1.98K | — | 2026-06-13 | 2026-06-16 |
Owen Adams Catherine Director · Restricted stock units · 2026-06-13 | Exercise | 1.98K | — | 2026-06-13 | 2026-06-16 |
SEC filings
EDGAR filings in AGIO · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.